Gene Therapy to Target Lewis Y Antigen for Lung Cancer by Bristol-Myers Squibb for Lung Cancer: Likelihood of Approval
Gene Therapy to Target Lewis Y Antigen for Lung Canceris under clinical development by Bristol-Myers Squibb and currently in Phase I for Lung Cancer.
Source: pharmaceutical-technology.com